In parallel, the short isoform <i>CNTNAP2-203</i> has recently emerged as an oncogenic driver in oral squamous cell carcinoma, where its selective upregulation amplifies EGFR-E2F1 signaling and promotes tumor progression. Here, E2F1 is linked to neoplasm.